BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anderson BJ, Calfee CS, Liu KD, Reilly JP, Kangelaris KN, Shashaty MGS, Lazaar AL, Bayliffe AI, Gallop RJ, Miano TA, Dunn TG, Johansson E, Abbott J, Jauregui A, Deiss T, Vessel K, Belzer A, Zhuo H, Matthay MA, Meyer NJ, Christie JD. Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study. Crit Care 2019;23:400. [PMID: 31818332 DOI: 10.1186/s13054-019-2684-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Spinetti T, Meisel C, von Gunten S, Schefold JC. Immune biomarker-based enrichment in sepsis trials. Crit Care 2020;24:58. [PMID: 32075672 DOI: 10.1186/s13054-020-2774-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Puskarich MA, Jennaro TS, Gillies CE, Evans CR, Karnovsky A, McHugh CE, Flott TL, Jones AE, Stringer KA; RACE Investigators. Pharmacometabolomics identifies candidate predictor metabolites of an L-carnitine treatment mortality benefit in septic shock. Clin Transl Sci 2021. [PMID: 34216108 DOI: 10.1111/cts.13088] [Reference Citation Analysis]
3 Nunnally ME, Ferrer R, Martin GS, Martin-Loeches I, Machado FR, De Backer D, Coopersmith CM, Deutschman CS; Surviving Sepsis Campaign Reasearch Committee. The Surviving Sepsis Campaign: research priorities for the administration, epidemiology, scoring and identification of sepsis. Intensive Care Med Exp 2021;9:34. [PMID: 34212256 DOI: 10.1186/s40635-021-00400-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Li X, Shen H, Zhou T, Cao X, Chen Y, Liang Y, Lu T, He J, Dou Z, Liu C, Tang Y, Zhu Z. Does an increase in serum FGF21 level predict 28-day mortality of critical patients with sepsis and ARDS? Respir Res 2021;22:182. [PMID: 34154595 DOI: 10.1186/s12931-021-01778-w] [Reference Citation Analysis]
5 Mabrey FL, Morrell ED, Bhatraju PK, Sathe NA, Sakr SS, Sahi SK, West TE, Mikacenic C, Wurfel MM. Plasma Soluble CD14 Subtype Levels Are Associated With Clinical Outcomes in Critically Ill Subjects With Coronavirus Disease 2019. Crit Care Explor 2021;3:e0591. [PMID: 34909698 DOI: 10.1097/CCE.0000000000000591] [Reference Citation Analysis]
6 Hawkes MT, Leligdowicz A, Batte A, Situma G, Zhong K, Namasopo S, Opoka RO, Kain KC, Conroy AL. Pathophysiology of Acute Kidney Injury in Malaria and Non-Malarial Febrile Illness: A Prospective Cohort Study. Pathogens 2022;11:436. [DOI: 10.3390/pathogens11040436] [Reference Citation Analysis]
7 Balanza N, Erice C, Ngai M, Varo R, Kain KC, Bassat Q. Host-Based Prognostic Biomarkers to Improve Risk Stratification and Outcome of Febrile Children in Low- and Middle-Income Countries. Front Pediatr 2020;8:552083. [PMID: 33072673 DOI: 10.3389/fped.2020.552083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Barichello T, Generoso JS, Singer M, Dal-Pizzol F. Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review. Crit Care 2022;26:14. [PMID: 34991675 DOI: 10.1186/s13054-021-03862-5] [Reference Citation Analysis]